Abstract
The term "lifestyle disease" was introduced in response to the proposal by the Council on Public Health in Japan (December, 1996), replacing the traditional name of "adult disease". This new term represents a concept of "a group of diseases where symptomatic appearances and progress are affected by living practices including eating, exercising, rest, smoking, and drinking". Generally, the development of a lifestyle disease is influenced by external environmental factors such as various pathogenic organisms, toxic substances and hereditary factors. However, it is clear that in many cases the development and aggravation of diseases such as diabetes, high blood pressure, cancer, cerebrovascular disease and heart disease also deeply involves lifestyle habits such as eating, exercise, and rest.
References
4. Wallace RB. Maxcy-Rosenau-Last public health & preventive medicine. 1998. 14th ed. Stamford: Appleton & Lange.
5. Centers for Disease Control and Prevention. Targeting Tobacco Use-The Nation's Leading Cause of Death 2003. 2003. Atlanta: Department of Helath and Human Services.
7. Kim IS, Jee SH, Ohrr H, Yi SW. Effects of smoking on the mortality of lung cancer in Korean men. Yonsei Med J. 2001. 42(2):155–160.
8. Jee SH, Suh I, Kim IS, Appel LJ. Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol: the Korea Medical Insurance Corporation Study. JAMA. 1999. 282(22):2149–2155.
9. DeVita VT, Rosenberg SA, Hellman S. Cancer:principles and practice of oncology. 2001. 6th ed. Philadelphia: Lippincott, Williams & Wilkins.
10. Kaplan NM. Clinical hypertension. 1998. 7th ed. Baltimore: Williams & Wilkins.
11. Izzo JL, Black HR. Hypertension primer:the essentials of high blood pressure. 1999. Baltimore: Lippincott Williams & Wilkins.
12. Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE. Clinical oncology. 2000. New York: Churchill Livingstone.
13. Yoo KY, Kang D, Park SK, Kim SU, Kim SU, Shin A, et al. Epidemiology of breast cancer in Korea:occurrence, high-risk groups, and prevention. J Korean Med Sci. 2002. 17(1):1–6.
14. Suh I, Oh KW, Lee KH, Psaty BM, Nam CM, Kim SI, et al. Moderate dietary fat consumption as a risk factor for ischemic heart disease in a population with a low fat intake: a case-control study in Korean men. Am J Clin Nutr. 2001. 73(4):722–727.
15. Cutler JA, Follmann D, Elliott P, Suh I. An overview of randomized trials of sodium reduction and blood pressure. Hypertension. 1991. 17:Suppl 1. I27–I33.
16. Jee SH, He J, Appel LJ, Whelton PK, Suh I, Klag MJ. Coffee consumption and serum lipids:a meta-analysis of randomized controlled clinical trials. Am J Epidemiol. 2001. 153(4):353–362.
17. Jee SH, He J, Whelton PK, Suh I, Klag MJ. The effect of chronic coffee drinking on blood pressure:a meta-analysis of controlled clinical trials. Hypertension. 1999. 33(2):647–652.
19. Pickup JC, Williams G. Textbook of diabetes. 1997. Cambridge: Blackwell Science.
20. Friedenreich CM. Physical activity and cancer prevention: from observational to intervention research. Cancer Epidemiol Biomarkers Prev. 2001. 10(4):287–301.
21. Braunwald E, Zipes DP, Libby P. Heart disease:a textbook of cardiovascular medicine. 2001. 6th ed. Philadelphia: WB Saunders.
22. Centers for Disease Control and Prevention. The Promise of Prevention. 2003. Atlanta: Department of Helath and Human Services.
23. Cutler JA, Follmann D, Elliott P, Suh I. An overview of randomized trials of sodium reduction and blood pressure. Hypertension. 1991. 17:Suppl 1. I27–I23.
24. Brownson RC, Remington PL, Davis JR. Chronic disease epidemiology and control. 1993. Washington: American public health association.
26. Department of Health and Human Services. Healthy People 2010. 2000. The Institute.